Oncopeptides starts commercialization of Pepaxti in Europe

/PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat...

Related Keywords

Germany ,Sweden ,Austria ,Stockholm ,German ,Swedish ,Jakob Lindberg ,National Association Of Statutory Health Insurance Funds ,European Union ,European Commission ,Global Head Of Corporate Communications ,Nasdaq Stockholm ,Federal Joint ,Marketing Authorization ,European Economic Area ,National Association ,Statutory Health Insurance Funds ,Corporate Communications ,Peptide Drug Candidate ,Mid Cap ,